MONOGRAPH LIBRARY
Weight, glucose, insulin, GLP-1s, fasting protocols, body recomposition.
Continuous glucose monitoring devices have been the standard of care in insulin-dependent diabetes for over a decade — Dexcom and Abbott Libre systems track interstitial glucose every 1–15 minutes via a small subcutaneous sensor worn for 10–15 days,…
Dual-energy X-ray absorptiometry (DEXA, sometimes written DXA) is the gold-standard imaging modality for measuring bone mineral density and the most accurate consumer-accessible method for measuring body composition (fat mass, lean mass, visceral…
Lumen is a consumer-direct handheld device that measures CO₂ concentration in a single exhaled breath, computes the respiratory exchange ratio (RER), and reports a number indicating whether the user is metabolically in a fat-burning or…
Consumer microbiome testing has emerged as a substantial commercial category over the past decade, with companies including Viome, ZOE, Sun Genomics, Thryve, DayTwo, and various direct-to-consumer offerings sequencing stool samples and returning…
Small intestinal bacterial overgrowth (SIBO) describes an excessive concentration of bacteria in the small intestine, traditionally defined as ≥10⁵ colony-forming units per mL on small bowel aspirate. The condition has been increasingly diagnosed…
VO2max — maximum oxygen consumption during exhaustive exercise — is the single most predictive fitness metric for all-cause mortality across multiple longitudinal cohort studies. Companion to the existing Vanguard VO2max Maximization Protocols…
5-Amino-1-methylquinolinium iodide (5-amino-1MQ) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), the enzyme that methylates nicotinamide using S-adenosylmethionine (SAM) as a methyl donor. Two metabolic problems flow from…
Alpha-glucosidase inhibitor: approved for type 2 diabetes, longevity potential in animal models
A metabolic intermediate supporting cellular energy production and muscle protein synthesis
Failed Drug Candidate With Misleading GRAS Status
Innate Repair Receptor Agonist in Phase 2 Development
Essential water-soluble vitamins supporting energy metabolism, neurological function, and stress resilience
A plant alkaloid with emerging evidence for metabolic and cardiovascular support, requiring clinical context
Bimagrumab (BYM338) is a fully human monoclonal antibody that binds and blocks the activin receptor type II (ActRII), preventing signaling from myostatin, activin A, and other ActRII ligands that negatively regulate skeletal muscle mass. By blocking…
Emerging Peptide for Tissue Repair Research
Bupropion-naltrexone sustained-release (brand name Contrave) is an FDA-approved combination weight-loss drug, approved in September 2014. It pairs bupropion — a norepinephrine and dopamine reuptake inhibitor used as an antidepressant and…
Bovine first-milk concentrate for immune support and gut barrier health
The gold standard for muscle energy and strength, backed by decades of research and approved globally
A leucine metabolite supporting muscle protein synthesis and exercise recovery with solid clinical evidence
Potent Modified IGF-1 With Extreme Abuse Potential
A prebiotic fiber supporting gut microbiota, digestive health, and metabolic markers
An essential branched-chain amino acid crucial for muscle protein synthesis and metabolic signaling
The Metabolic Workhorse for Glucose Control and Longevity
Odd-chain saturated fatty acid for metabolic flexibility and cellular signaling
Qsymia is a fixed-dose combination of immediate-release phentermine (a sympathomimetic appetite suppressant) and extended-release topiramate (an anticonvulsant with appetite-reducing properties through multiple mechanisms), FDA-approved in July 2012…
Live beneficial bacteria for microbiome support and digestive wellness
Setmelanotide (brand name Imcivree, Rhythm Pharmaceuticals) is a melanocortin-4 receptor (MC4R) agonist administered as a daily subcutaneous injection. It is FDA-approved for chronic weight management in patients aged 6 years and older with obesity…
Approved for type 2 diabetes, heart failure, and chronic kidney disease; off-label longevity and cardiometabolic optimization
Cruciferous phytochemical with potent anti-cancer and detoxification support
Conditionally essential amino acid for cardiac, neurological, and metabolic support
Four investigational compounds reshaping the weight-loss and metabolic-disease conversation in 2025-2026. What the trials actually showed, where each one differs mechanistically, and how to think about them now versus when they reach the pharmacy.
Tirzepatide is a synthetic peptide agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. FDA-approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic…
Pentacyclic triterpenoid from apple peel with emerging longevity potential
Unregulated training modality; emerging evidence for strength and hypertrophy at low loads
Unregulated practice; emerging evidence for immune function and stress resilience; cardiovascular precautions necessary
Device-regulated; FDA-cleared for muscle stimulation; consumer devices vary in quality and efficacy
Skeletal muscle is increasingly recognized in the longevity literature as a metabolic and endocrine organ — a glucose disposal sink, an endocrine signaling source (myokines), a reserve for the metabolic challenges of acute illness and recovery, and…
Maximal oxygen uptake (VO₂max) is the single most predictive fitness metric for all-cause mortality across multiple population studies — more predictive than smoking, hypertension, diabetes, or any other commonly measured risk factor. Each one-MET…
The carnivore diet — exclusive or near-exclusive consumption of animal products, eliminating all plants — has grown from a fringe practice associated with Shawn Baker and Mikhaila Peterson around 2018 into a major cultural movement with millions of…
The fasting-mimicking diet (FMD) is a 5-day, low-calorie, low-protein, low-carbohydrate dietary protocol developed by Valter Longo's group at USC and commercialized as the Prolon program (L-Nutra). The protocol provides about 4,600 kJ (\(~1,100\)…
Protocol Guide Series / April 2026 / FOR VANGUARD MEMBERS ONLY — Gut Health & Immune Optimization Protocol
Prolonged water-only or near-water-only fasting — typically 3, 5, or 7 days — has emerged from a niche longevity practice into a recurring feature of the men's optimization conversation. The mechanistic case is interesting: prolonged fasting drives…
Time-restricted eating (TRE) is the practice of confining all daily caloric intake to a defined window — most commonly 8 hours (16:8), 10 hours (14:10), 6 hours (18:6), or one meal per day (23:1, OMAD). The intervention has exploded in cultural…
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), also called acadesine or simply AICA riboside, is an AMP analog that activates AMP-activated protein kinase (AMPK) — the central cellular energy sensor and metabolic regulator. Activation of…
Metformin is the most-prescribed glucose-lowering medication in the world, with over six decades of clinical use, validated efficacy in type 2 diabetes, an extensive safety database, an emerging longevity literature, and a generic cash price of…
Glucagon-Like Peptide-1 Agonists for Metabolic Optimization and Weight Management
The U.S. Recommended Daily Allowance (RDA) for protein is 0.8 grams per kilogram of body weight per day. That number was set decades ago based on short-term nitrogen-balance studies in young sedentary adults, and it represents the minimum required…
Rapamycin (sirolimus) and metformin are the two off-label drugs most often discussed in the longevity optimization conversation. Both have substantial preclinical evidence for healthspan or lifespan benefit, both have been the subject of ongoing…
The GLP-1 receptor agonist class has revolutionized obesity medicine over the past five years, but "GLP-1" as a single category obscures three quite different products. Semaglutide (Wegovy for obesity, Ozempic for T2D) is a single GLP-1 receptor…
Yohimbine is an indole alkaloid from the bark of the Pausinystalia yohimbe tree, used as a traditional aphrodisiac in West African medicine and prescribed for erectile dysfunction in the U.S. and Europe before sildenafil became available in 1998.…
Bug report, content request, or general comment — we read everything.